WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke CYTOVALE wurde als Wortmarke am 28.09.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1570059 |
| Länder | 
|
| Basismarke |
Nr. ,
01. Oktober 2024
|
| Anmeldedatum | 28. September 2020 |
| Ablaufdatum | 28. September 2030 |
Markeninhaber
150 Executive Park Blvd, Suite 4100
San Francisco CA 94134
US
San Francisco CA 94134
US
Markenvertreter
88 Guy Place, Suite 405
San Francisco CA 94105
US
Waren und Dienstleistungen
09
Scientific instruments for biological testing, biological
sample processing, scientific research, and laboratory use,
namely, automated instruments for performing diagnostic
assays and automated instruments for performing sample
preparations; kits comprising scientific instruments,
namely, automated instruments for performing diagnostic
assays and automated instruments for performing sample
preparations, assays and reagents for biological testing,
and for biological sample processing, all for scientific
research and laboratory use; digital microscope cameras and
scanners for creation of digital images for medical use
10
Medical devices for use in the fields of oncology,
hematology, and for diagnosis and treatment of sepsis;
medical diagnostic instruments for the analysis of body
fluids; medical testing kits (term considered too vague by
the International Bureau - Rule 13 (2) (b) of the
Regulations); blood testing apparatus; apparatus for
carrying-out diagnostic tests for medical purposes, namely,
flow cytometry apparatus; apparatus for diagnostic purposes,
namely, medical diagnostic apparatus in the fields of
oncology, hematology, and for detecting sepsis; automated
medical instruments which use electronics and optical
fluorescence flow cytometry to analyze human cells;
ultraviolet visible and near infrared fluorescence analyzers
for medical use and components therefor; imaging platforms,
namely, medical imaging apparatus for imaging and analysis
of cells and cell organelles, molecular diagnostics and
imaging cytometry for medical use; medical micro imaging
apparatuses for imaging and analysis of bacteriums, viruses,
cells and cell organelles for medical use and components
therefor; medical micro imaging apparatuses for molecular
diagnostics and cytometry for medical diagnostic use and
components therefor; medical apparatuses for the examination
and analysis of proteins, peptides, antibodies and molecules
for medical diagnostic use and components therefor; digital
imaging platforms, namely, medical micro imaging apparatus
for acquiring and processing microscopic images for medical
diagnostic use; digital imaging platforms, namely, medical
micro imaging apparatus for use in the examination of cells,
proteins and peptides for medical diagnostic use; diagnostic
apparatus for medical use, namely, fluorescent protein
imaging systems, fluorescent protein monitoring systems for
use in performing fluorescent antibody technique analysis
and fluorescent protein technique analysis, computed
tomography scanners, fluorescent microscope systems for use
in performing fluorescent antibody technique analysis and
fluorescent protein technique analysis, automatic cell
sorting systems for use in flow cytometry analysis and in
fluorescence activated cell sorting, flow cytometers, sample
preparation device, and related data management software
sold as a unit medical instruments for processing biological
samples medical and diagnostic apparatus for use in analysis
of gene expression tests, analysis of gene expression
profiling assays, analyzing genetic information, analyzing
and detecting protein biomarkers, analyzing clinical data,
and/or analyzing demographic information (term considered
too vague by the International Bureau - Rule 13 (2) (b) of
the Regulations); medical and diagnostic apparatus for
analysis of biomarker levels and/or relative expression of
host response genes, medical and diagnostic apparatus for
analyzing gene expression tests using bioinformatics and
machine learning algorithms, medical and diagnostic
apparatus for analyzing gene expression tests, gene
expression profiling assays, genetic information, protein
biomarkers, clinical data and/or demographic information to
aid treatment decisions surgical and medical apparatus and
instruments for use in analysis of gene expression, protein
expression, metabolite expression, inflammation, immune-
suppression, immune disorders (term considered too vague by
the International Bureau - Rule 13 (2) (b) of the
Regulations); diagnostic test apparatus for analysis of gene
expression, protein expression, metabolite expression,
inflammation, immune- suppression, immune disorders;
diagnostic testing kits in this class consisting primarily
of probes, buffers and reagents for use in microbial testing
(term considered too vague by the International Bureau -
Rule 13 (2) (b) of the Regulations); point of care medical
devices, namely, devices for analysis of gene expression,
protein expression, metabolite expression, inflammation,
immune-suppression and immune disorders
44
Medical testing and analysis for diagnostic or treatment
purposes; providing medical information; medical services;
medical treatment and medical diagnostic testing services;
oncological, hematological and sepsis testing services for
medical purposes; medical screening services; medical
advisory services relating to disease including providing
disease risk assessment and related information;
comprehensive clinical laboratory medical testing services,
namely, anatomic pathology testing, flow cytometry testing,
molecular based testing, cytogenetics testing, and
fluorescent in situ hybridization (fish) testing; providing
medical test results of clinical and anatomic pathology
tests by means of a computerized online ordering and
retrieval service; medical analysis services in the fields
of cytometry, oncology, and hematology
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 15. Dezember 2022 | 2022/51 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 31. August 2022 | 2022/38 Gaz | RAW: Limitation | |
| 20. Mai 2022 | 2022/22 Gaz | US | RAW: Division or Merger of Basic Registration |
| 02. Dezember 2021 | 2021/48 Gaz | JP | Ablehnung |
| 26. Mai 2021 | 2021/21 Gaz | EM | Ablehnung |
| 28. September 2020 | 2020/52 Gaz | US | Eintragung |
ID: 141570059